Évaluation du niveau de connaissance des patients sur la gestion du traitement par les anti-vitamines K dans un service de médecine interne

Belhadj, L.; Bellakhal, S.; Somaï, M.; Kaab, B. Ben; Jomni, T.; Douggui, M.H.

doi:10.1016/j.revmed.2018.03.248

Cited by 2 publications

(4 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In our study, most of the patients reacted correctly when they forgot to take their medication (19 patients). These patients continued their treatment normally and avoided doubling the dose at the next intake, with an awareness in the group that did not forget to take their medication of the need to avoid this reaction, which was almost total knowledge (except in three cases) of what to do if they forgot to take their medication, which is slightly higher than the results of the study by Belhadj et al 13 In terms of risk management of side effects, which was the focus of our study, 72 patients reported the occurrence of events following treatment with an average of 2.6 events reported per patient (patients generally reported at least two side effects).…”

Section: Discussionmentioning

confidence: 57%

Section: Discussionmentioning

confidence: 57%

“…It remains partly similar to other studies carried out with the same objective of following up and accompanying patients. 13,14 Therapeutic education is an essential and indispensable means of introducing capecitabine treatment. It must take into account the level of education of the patients who were, in our study, in 57% of the cases illiterate and 23% not exceeding the primary level, and this by ensuring a fluid and simple transmission of information while paying attention to the good assimilation of the given advice and information.…”

Section: Discussionmentioning

confidence: 99%

“…It remains partly similar to other studies carried out with the same objective of following up and accompanying patients. 13,14…”

Section: Discussionmentioning

confidence: 99%

See 3 more Smart Citations

Assessment of patients’ knowledge of their treatment with capecitabine at the National Institute of Oncology in Rabat

Nouibi

Chefchaouni

Bechar³

et al. 2023

J Oncol Pharm Pract

View full text Add to dashboard Cite

Introduction Capecitabine is a molecule of choice in the therapeutic arsenal of anticancer drugs used in Morocco for the treatment of breast cancer and colorectal cancer. Its frequent use imposes a follow-up and a post-prescription monitoring of the treatment modalities as well as the adverse events that may occur following its administration. Objective The objective of this study is to evaluate the level of knowledge of patients in the day hospital of an oncology facility about their treatment with capecitabine. Materials and methods This is a prospective study conducted over a period of 2 months (January–February 2022) at the day hospital in the National Institute of Oncology in Rabat, and it was conducted using a questionnaire in order to evaluate patients’ knowledge about their treatment with capecitabine. Results This study involved 95 patients, 76% claimed to have ever received pharmaceutical advice on capecitabine treatment. The main indications were colorectal and breast cancer. Ninety seven percent knew the indication for capecitabine and the action of the molecule on the relevant tumor. Eighty three percent receiving capecitabine therapy reported the occurrence of side effects and hand-foot syndrome was the most reported in 31.2% of the total listed side effects. Discussion Capecitabine is an oral treatment of choice for colorectal and breast cancer in Morocco. Therapeutic education happens to be an effective tool in order to guarantee the best effectiveness and manage the possible side effects that can occur during the treatment.

show abstract

Section: Discussionmentioning

confidence: 57%

Section: Discussionmentioning

confidence: 57%

Section: Discussionmentioning

confidence: 99%

“…It remains partly similar to other studies carried out with the same objective of following up and accompanying patients. 13,14…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations